Support Burnet’s COVID-19 emergency response
COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
Adolescent girls and young women are disproportionately affected by HIV in sub-Saharan Africa where they are up to 8 times more likely to be infected compared to their male counterparts.
A major biological mechanism driving this increased risk is subclinical genital inflammation due to the presence of “non-optimal” vaginal microbiota depleted of beneficial lactobacillus species.
This study will formulate and perform preclinical safety studies of an anti-inflammatory microbiota metabolite for in-vivo evaluation.
2019
Dr Anna Hearps Associate Professor Catriona Bradshaw Dr Simon Cook Dr Simon Moulton Dr Seyoum Ayenhunie
NHMRC
For any general enquiries relating to this project, please contact:
Head of Life Sciences; Head of Tachedjian Laboratory (Retroviral Biology and Antivirals)
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2020 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.
